Urinary Biomarker Study With Sulindac and Difluoromethylornithine
by on Tuesday, July 10th, 2012 | No Comments
Condition: Focus of Study: Drug Response Biomarkers, Chemoprevention, Neoplasms
Interventions: Drug: difluoromethylornithine; Drug: Sulindac
Sponsors: Cancer Prevention Pharmaceuticals, Inc.; Cancer Prevention Pharmaceuticals, Inc.; University of Arizona
Not yet recruiting – verified July 2012
Continue reading here: Urinary Biomarker Study With Sulindac and Difluoromethylornithine